Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00243074 · OUTCOME

Adverse Event Rates

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery · Source last updated 2018-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Daily during protocol treatment

What was measured

Adverse events per the NCI Common Toxicity Criteria version 3.0 that were possibly, probably or definitely related to protocol treatment. See adverse event tables for specific details.

Analysis population: All patients who received protocol treatment were assessed for adverse events. See adverse event tables for specific details.

Groups in this outcome

AZD2171 (Cediranib Maleate)

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
AZD2171 (Cediranib Maleate)47

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
AZD2171 (Cediranib Maleate)47Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        47
denoms
  1. counts
    1. group Id
      OG000
      value
      47
    units
    Participants
description
Adverse events per the NCI Common Toxicity Criteria version 3.0 that were possibly, probably or definitely related to protocol treatment. See adverse event tables for specific details.
groups
  1. id
    OG000
    title
    AZD2171 (Cediranib Maleate)
param Type
COUNT_OF_PARTICIPANTS
population Description
All patients who received protocol treatment were assessed for adverse events. See adverse event tables for specific details.
reporting Status
POSTED
time Frame
Daily during protocol treatment
title
Adverse Event Rates
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice